Loading clinical trials...
Loading clinical trials...
In this study, the investigators will determine the utility of Tamoxifen, a non-cytotoxic agent, to improve quality of life, biochemical parameters, and bone marrow involvement in systemic mastocytosi...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Mayo Clinic
NCT07562542 · Systemic Mastocytosis, KIT-D816V Mutation
NCT07142473 · Cutaneous Mastocytosis, Systemic Mastocytosis
NCT05186753 · SSM, Mastocytosis, Indolent, and more
NCT00449748 · Systemic Mastocytosis
NCT03770273 · Indolent Systemic Mastocytosis
Mayo Clinic
Rochester, Minnesota
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions